IRIS
GUIDO, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.426
SA - Sud America 1.442
NA - Nord America 1.309
EU - Europa 585
AF - Africa 179
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.946
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.996
US - Stati Uniti d'America 1.173
BR - Brasile 1.037
VN - Vietnam 767
CN - Cina 659
HK - Hong Kong 332
FR - Francia 169
KR - Corea 164
AR - Argentina 151
BD - Bangladesh 90
IT - Italia 84
IQ - Iraq 73
EC - Ecuador 64
DE - Germania 63
MX - Messico 58
IN - India 56
RU - Federazione Russa 56
CO - Colombia 51
ZA - Sudafrica 48
GB - Regno Unito 44
NL - Olanda 41
ID - Indonesia 38
CL - Cile 36
PK - Pakistan 35
TR - Turchia 27
MA - Marocco 26
VE - Venezuela 25
CA - Canada 24
TN - Tunisia 24
UZ - Uzbekistan 23
FI - Finlandia 22
PY - Paraguay 22
UY - Uruguay 22
EG - Egitto 19
SA - Arabia Saudita 19
UA - Ucraina 19
PE - Perù 18
DZ - Algeria 15
ES - Italia 15
PH - Filippine 14
BO - Bolivia 13
KZ - Kazakistan 13
NP - Nepal 12
AG - Antigua e Barbuda 11
JO - Giordania 11
KE - Kenya 11
MY - Malesia 11
AZ - Azerbaigian 10
ET - Etiopia 10
PL - Polonia 10
JP - Giappone 9
SE - Svezia 9
PA - Panama 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
AL - Albania 6
AT - Austria 6
KW - Kuwait 6
LB - Libano 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
IR - Iran 5
KG - Kirghizistan 5
OM - Oman 5
QA - Qatar 5
SN - Senegal 5
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
CY - Cipro 4
HN - Honduras 4
IL - Israele 4
LT - Lituania 4
PS - Palestinian Territory 4
RS - Serbia 4
AU - Australia 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
LK - Sri Lanka 3
LY - Libia 3
MD - Moldavia 3
AO - Angola 2
BW - Botswana 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
LV - Lettonia 2
NI - Nicaragua 2
PR - Porto Rico 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TG - Togo 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZM - Zambia 2
Totale 7.927
Salva come PNG Salva come JPEG
Città #
Singapore 740
San Jose 440
Hong Kong 328
Ho Chi Minh City 290
Hefei 272
Ashburn 253
Beijing 177
Seoul 159
Hanoi 156
Lauterbourg 154
Dallas 117
São Paulo 87
Da Nang 41
Amsterdam 37
Rio de Janeiro 35
Los Angeles 30
Munich 28
Haiphong 27
Baghdad 25
New York 25
Santa Clara 25
Mexico City 24
Tianjin 24
Biên Hòa 23
Brasília 22
Rende 22
Dhaka 20
Hải Dương 20
Tashkent 20
Johannesburg 18
Fortaleza 17
Guayaquil 17
Quito 17
Brooklyn 16
Curitiba 16
Helsinki 16
Montevideo 16
Belo Horizonte 15
Campinas 15
Phoenix 15
Porto Alegre 15
Cape Town 13
Council Bluffs 12
Medellín 12
Bogotá 11
Frankfurt am Main 11
Rome 11
Santiago 11
St John's 11
Amman 10
Istanbul 10
Lima 10
Addis Ababa 9
Baku 9
Buenos Aires 9
Can Tho 9
Guangzhou 9
Joinville 9
Nairobi 9
Nova Iguaçu 9
Salvador 9
Seattle 9
Stockholm 9
Tunis 9
Boston 8
Cairo 8
Carapicuíba 8
Guarulhos 8
Jeddah 8
Karachi 8
Lấp Vò 8
Osasco 8
Phủ Lý 8
Tokyo 8
Warsaw 8
Asunción 7
Casablanca 7
Chennai 7
Erbil 7
Franca 7
Goiânia 7
London 7
Moscow 7
Natal 7
Ninh Bình 7
Panama City 7
Quảng Ngãi 7
Sorocaba 7
Thái Nguyên 7
Viamão 7
Volta Redonda 7
Bắc Ninh 6
Bến Tre 6
Cao Lanh 6
Jakarta 6
La Paz 6
Lahore 6
Montreal 6
Orem 6
Recife 6
Totale 4.298
Salva come PNG Salva come JPEG
Nome #
A State-of-the-Art Review of Ophthalmological Indications for a Cesarean Section: Is There a Patient for Whom a Cesarean Section Is Really Indicated? 113
A NEW ULTRASOUND CRITERIUM FOR THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME: PREDICTIVITY OF THE STROMA/AREA RATIO 93
A WHO 2021-based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT-A cycles 87
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 78
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 77
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 74
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 73
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 71
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 71
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 70
A first stage placental site trophoblastic tumor: a case report and review of literature 70
Value of PGT-A when only one or two blastocysts are obtained: propensity-score matching and cost-effectiveness study 69
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 66
Progesterone: The Key Factor of the Beginning of Life 66
Differences in AMH levels in the four polycystic ovary syndrome phenotypes based on Rotterdam criteria 64
EFFECT OF THE INSULIN-SENSITIZING DRUG METFORMIN ON THE GROWTH HORMONE RESPONSE TP GROWTH HORMONE RELEASING HORMONE IN OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH FOOD INGESTION 63
Synchronous ovarian and uterine tumours: a case report of an unusual association 62
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 62
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 62
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol with drospirenone in normal weight women with polycystic ovary syndrome 62
Endocrinology: Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome 61
INSULIN SECRETION IN POLYCYSTIC OVARY DISEASE (PCOD): A MULTIFACTORIAL PROBLEM 61
INSULIN RESISTANCE AND WOMEN'S HEALTH 59
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 59
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE 58
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 58
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS RESPONSE TO NALAXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 58
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 57
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 57
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 57
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 56
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 56
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE. 56
Sex ratio at birth: causes of variation and narrative review of literature 55
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 55
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC SYNDROME 55
VAGINAL MESH REPAIR SYSTEMS FOR PELVIC ORGAN PROLAPSE: ANATOMICAL STUDY COMPARING OUTSIDE-IN VS INSIDE-OUT-TECHNIQUES 55
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 55
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 55
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 55
ENDOSCOPIC SURGERY IN OVARIAN ENDOMETRIOSIS: HISTOPATOLOGIC OBSERVATIONS ON THE LOSS OF FOLLICULAR TISSUE DURING TREATMENT 54
ALTERATION OF GHRELIN-NEUROPEPTIDE Y NETWORK IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME: ROLE OF HYPERINSULINISM 54
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 54
RECOMBINANT versus URINARY FOLLICLE STIMULATING HORMONE (FSH) IN THE LOW-DOSE REGIMEN IN ANOVULATORY PATIENTS WITH POLICYSTYC OVARY SYNDROME (PCOS): A SAFER AND MORE EFFECTIVE TREATMENT 54
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 53
Metformin Effects tin Ovarian Ultrasound Appearance and Steroidogenic Function in Normal Weight, Normoinsulinemic Women with Polycystic Ovary Syndrome: A Randomized, Double Blind, Placebo-Controlled Clinical Trial 53
GH RESPONSE TO FOOD INTAKE IN OBESE pcos WOMEN: EFFECT OF METFORMIN 53
EFFECT OF PIOGLITAZONE TREATMENT ON THE ADRENAL ANDROGEN REPONSE TO CORTICOTROPHIN IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 52
METFORMIN TREATMENT DOSE NOT AFFECT TOTAL LEPTIN LEVELS AND FREE LEPTIN INDEX IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 51
DETRIMENTAL EFFECT OF AGE ON THE OVARIAN RESPONSE TO GONADOTROPIN AND ON PREGNANCY RATE IN POLYCYSTIC OVARIAN SYNDROME WOMEN 51
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 51
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 50
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 50
L'INDUZIONE DELL'OVULAZIONE CON FSH PURIFICATO IN PAZIENTI AFFETTE DA SINDROME DELL'OVAIO POLICISTICO: POSSIBILI VANTAGGI DELLA TERAPIA A BASSE DOSI 50
IS THERE A ROLE FOR ISOLAVONES IN THE THERAPEUTIC APPROCH TO POLYCYSTIC OVARY SYNDROME? RESULTS FROM A PILOT STUDY 50
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 50
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 49
How should the best human embryo in vitro be? Current and future challenges for embryo selection 49
Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down syndrome 49
Assessment of insulin resistance in lean women with polycystic ovary syndrome 49
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 49
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 49
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 49
OPIOIDS AND GROWTH HORMONE IN POLYCYSTIC OVARY SYNDROME. EFFECT OF FEEDING. 48
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 48
PIOGLITAZONE ADMINISTRATION IN HYPERINSULINEMIC WOMEN WITH PCOS DECREASES THE ADRENAL ANDROGEN RESPONSE TO CORTICOTROPHIN-RELEASING FACTOR 48
CONTRACCEZIONE ORMONALE E SINDROME DELL'OVAIO POLICISTICO 48
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study 48
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 48
Posterior mesh fixation versus non-fixation in sacrocolpopexy: A randomized clinical trial 48
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 48
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 47
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 47
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 46
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 46
TOPICAL HAEMOSTATICS AND SEALANTS IN GYNAECOLOGICAL AND OBSTETRIC 3 SURGERY: STATE OF THE ART 46
EFFECT OF ACUTE SUPPRESSION OF FREE FATTY ACIDS BY ACIPIMOX IN POLYCYSTIC OVARIAN SYNDROME 46
GLI IPERANDROGENISMI E LA SINDROME DELL'OVAIO POLICISTICO 45
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 45
APPROCCIO DIAGNOSTICO ALLA COPPIA STERILE 45
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 45
Maternal and fetal outcomes of intraplacental choriocarcinoma complicated by fetomaternal hemorrhage: a systematic review 45
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 45
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 45
LA SINDROME DELL'OVAIO POLICISTICO 45
Perimesencephalic Subarachnoid Hemorrhage in Pregnancy 45
Ethinylestradiol-Chlormadinone Acetate Combination for the Treatment of Hirsutism and Hormonal Alterations of Normal-Weight Women with Polycystic Ovary Syndrome: Evalutation of Metabolic Impact 45
Using a 16-French Resectoscope as an Alternative Device in the Treatment of Uterine Lesions: A Randomized Controlled Trial 44
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation 44
ROLE OF GnRH ANALOG PITUITARY DESENSITIZATION IN INDUCTION OF OVULATION IN POLYCYSTIC OVARIAN SYNDROME 44
EFFECTS OF GHRELIN ADMINISTRATION ON GROWTH HORMONE SECRETION AND METABOLIC PARAMETERS IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 44
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 44
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism 44
Letter to the Editor - DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 44
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 44
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 44
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 44
IPERANDROGENISMO E SINDROME DELL'OVAIO POLICISTICO 44
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 43
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 43
Totale 5.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.335
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 1 0 0 0 0 0
2023/20243 0 0 0 0 0 1 0 0 1 0 0 1
2024/20251.724 0 2 1 0 215 197 103 73 302 113 140 578
2025/20266.398 1.034 379 303 770 1.347 508 791 340 417 509 0 0
Totale 8.126